Chapter 6 Muscarinic [,mʌskə‘rinik]毒蕈碱的 receptor agonists

Slides:



Advertisements
Similar presentations
INDIRECT CHOLINOMIMETICS Pharmacology Department
Advertisements

DIRECT CHOLINERGIC DRUGS Pharmacology Department
Direct cholinomimetic (Parasympathomimetics) Drugs
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Pharmacology of Cholinergic Agonists
INDIRECT CHOLINOMIMETICS
The Neuromuscular Junction
NEUROMUSCULAR JUNCTION DR. ZAHOOR ALI SHAIKH LECTURE
 Myasthenia gravis is a chronic autoimmune neuromuscular disease that is characterized by different degrees of weakness of the skeletal muscles of the.
Pharmacology-1 PHL 313 Parasympathetic Nervous System Third Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 5 th Lecture.
NEUROMUSCULAR JUNCTION BLOCKERS BY :DR ISRAA OMAR.
General functions of the sympathetic nervous system: (The alarm response or stress response) In emergency conditions: e.g. in cases of fight, flight, muscular.
Chapter 5 Autonomic Drugs.
Cholinergic agonists & Cholinergic antagonists
Cholinergics, anticholinergics and antcholinesterases Nervous System Peripheral NS Sensory nerves Motor nerves Central NS (Brain and Spinal cord) Sensory.
Cholinergic agonists By Dr.Sajid Hussain
MYASTHENIA GRAVIS ANESTHESIOLOGY Jasdeep Dhaliwal Clinical Rotation.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Autonomic Nervous System Prof. Alhaider 1433 H Revision of Physiology and Anatomy What is the peripheral Nervous System? What is the differences between.
DIRECT CHOLINERGIC DRUGS Prof. Hanan Hagar Pharmacology Department.
INDIRECT CHOLINOMIMETICS
Chapter six BASIC PHARMACOLOGYOF THE DIRECT-ACTING CHOLINOCEPTOR STIMULANTS.
NEUROMUSCULAR JUNCTION BLOCKERS
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Cholinergic drugs.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
DIRECT CHOLINERGIC DRUGS Profs. Abdalqader Alhaider & Hanan Hagar
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Drugs Affecting the Autonomic Nervous System
AUTONOMIC NERVOUS SYSTEM LECTURE 6 PHARMACOLOGY. Autonomic Pharmacology Autonomic Nervous System – This system is divided into two separate systems. –
Myasthenia Gravis.
Cholingeric Agonist Practice Questions. Pretest question The enzyme that is inhibited by echothiophate iodide isThe enzyme that is inhibited by echothiophate.
Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Neurology Chapter of IAP
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
Neuromuscular disorders
INDIRECT CHOLINOMIMETICS Pharmacology Department
INDIRECT CHOLINOMIMETICS
Cholinoceptor-Activating Drugs
Skeletal muscle relaxants
Myasthenia Gravis Johan Perrand Period 3.
Effect of Parasympathomimetic Drugs on Glandular Secretions in Rats
Drugs Affecting Autonomic Nervous System 2
inDirect Cholinomimetics
CHOLINESTERASES ANTICHOLINESTERASES PROPERTIES AND USES
Autonomic nervous pharmacology 2
Dr.Muhammad Ahmed. Contents Ans Sympathetic Parasypathetic Muscaranic receptors.
Drugs for Autonomic Nervous System
Anticholinesterase Drugs and Cholinergic Agonists
Cholinesterase Inhibitors (Indirect acting cholinergic agonists)
School of Pharmacy, University of Nizwa
Neurotransmitters SOMATIC NERVOUS SYSTEM Striated ACh muscle
Pharmacology of Autonomic Nervous System
Cholinergic Antagonist
Cholinergic Antagonist
Cholinergic Agents 1.
School of Pharmacy, University of Nizwa
Chapter 5 Autonomic Drugs.
INDIRECT CHOLINOMIMETICS
Adrenergic [ædrə‘nədʒik] agonists
Skeletal muscle relaxants
Intro to Neuromuscular blocking agents
inDirect Cholinomimetics
Skeletal muscle relaxants
Cholinesterase inhibitors
Cholinesterase inhibitors
Presentation transcript:

Chapter 6 Muscarinic [,mʌskə‘rinik]毒蕈碱的 receptor agonists

Subtypes and effects of cholinergic receptors Nicotine receptor N1 receptor: excitation of nerve ganglion N2 receptor promoting the contracting of skeletal muscle M1 receptor M3 receptor M2 receptor: inhibition of heart promoting the contracting of smooth muscle  [‘gæŋglɪən] 神经节  Muscarine receptor promoting the secretion of glands

Pilocarpine /,pailə'kɑ:pi:n; ,pi-/ M receptor agonist Pilocarpine /,pailə'kɑ:pi:n; ,pi-/ (毛果芸香碱,匹鲁卡品) Pharmacological effects: 1 Eye 1.1 Miosis /mai'əusis/缩瞳: Constriction of the sphincter /'sfiŋktə/括约肌 muscle of iris /'aiəris/虹膜 Pilocarpus

1.2 Reduce the intraocular [,intrə'ɔkjulə] 眼内的 pressure

1.3 Spasm /'spæzəm/痉挛 of accommodation 调节痉挛

Clinical application: 2 Increasing glandular /'ɡlændjulə/腺体的 secretion; 3 Promoting the contracting of smooth muscle. Clinical application: 1 Glaucoma[glɔ:‘kəumə] 青光眼 ( to decrease intraocular pressure) angle-closure glaucoma open-angle glaucoma 2 Iritis [ai'raitis]虹膜炎 3 Dry mouth 口干

Anti-cholinesterase agents /,kəuli'nestəreis/ 胆碱酯酶

Neostigmine /,ni:əu'stiɡmi:n; -min/ 新斯的明 Effects and mechanisms Stimulate skeletal muscle strongly, by: 1) Inhibiting Ach E→ Ach concentration↑ 2) Stimulating N2 receptors directly 3) Promoting the release of Ach at the motor nerve ending.

Clinical uses 1 Myasthenia /,maiəs'θi:niə/肌无力gravis 重症肌无力 2 Postoperative urinary /'juərinəri/retention and abdominal distention (/dis'tenʃən/膨胀/扩张) resulting from general anesthesia 3 Paroxysmal supraventricular tachycardia阵发性室上性心动过速 /,pærək‘sizməl/阵发性的 /,tæki'kɑ:diə/心动过速 4 Reverse the effects of non-depolarizing muscle relaxants 非去极化型肌松药

Adverse reactions: “Cholinergic crisis” A cholinergic crisis is an over-stimulation at a neuromuscular junction due to an excess of acetylcholine. The muscles stop responding to ACh, leading to flaccid [‘flæsɪd] 无力的paralysis, respiratory failure, other symptoms include increased sweating, salivation /,sæli'veiʃən/ 流涎, bronchial secretions along with miosis.

Contraindication 禁忌症 ileus['iliəs] , urinary obstruction, bronchial asthma 肠梗阻、泌尿道阻塞、支气管哮喘

Supplementary reading Myasthenia gravis is either an autoimmune or congenital [kən‘dʒenɪt(ə)l] 先天的neuromuscular disease that leads to fluctuating muscle weakness and fatigue. In the most common cases, muscle weakness is caused by circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction, inhibiting the excitatory effects of the neurotransmitter acetylcholine on nicotinic receptors at neuromuscular junctions. Alternatively, in a much rarer form, muscle weakness is caused by a genetic defect in some portion of the neuromuscular junction, that is inherited at birth as opposed to developing it through autoimmunity later in life or through passive transmission by the mother's immune system at birth. Myasthenia is treated medically with acetylcholinesterase inhibitors or immunosuppressants, and, in selected cases, thymectomy [θaɪ'mɛktəmi]胸腺切除术. The hallmark of myasthenia gravis is fatigability[,fætigə'biləti]易疲劳性. Muscles become progressively weaker during periods of activity, and improve after periods of rest. Muscles that control eye and eyelid movement, facial expressions, chewing, talking, and swallowing are especially susceptible. The muscles that control breathing and neck and limb movements can also be affected.

大纲要求 Objective and requirements Understand the concepts and classification of choline receptor agonists; Master the pharmacological actions, clinical applications, and adverse reactions of pilocarpine and neostigmine; Be familiar with the N-like and M-like functions of acetylcholine. Teaching contents (1) Conception and classification of choline receptor agonists; (2) N-like and M-like functions of acetylcholine; (3) M-like function (ocular function) induced by pilocarpine; the clinical applications and adverse reactions of pilocarpine (4) Pharmacological actions, in vivo process, characteristics, clinical applications, and adverse reactions of neostigmine.

Essential vocabulary Pharmacological effects Clinical application/ clinical use Adverse reaction Contraindication Miosis/Spasm of accommodation/Glandular secretion Glaucoma/Iritis/Myasthenia gravis Dry mouth/Abdominal distention/Urinary retention/Tachycardia/bradycardia Cholinergic crisis Anti-cholinesterase agents